ultraclear centrifugation tube (Danaher Inc)
Danaher Inc is a verified supplier 
Danaher Inc manufactures this product 
96
Structured Review
Danaher Inc
ultraclear centrifugation tube
Ultraclear Centrifugation Tube, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1649 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultraclear+centrifugation+tube/Ultra-Clear+Tube/pm41436444-305-39-42
Average 96 stars, based on 1649 article reviews
Ultraclear Centrifugation Tube, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1649 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ultraclear+centrifugation+tube/Ultra-Clear+Tube/pm41436444-305-39-42
Average 96 stars, based on 1649 article reviews
ultraclear centrifugation tube - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Suspension:Article Title: Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer. Article Snippet: To remove debris, samples were subjected to equilibriumdensity centrifugation: sample pellets were first resuspended in 250 μl HB and thenmixed 1:1 with 50% iodixanol solution Nature Communications | (2025) 16:11338 9 (50% v/vOptiPrepTM (Sigma), 25mMKCl, 5mMMgCl2, 10mMtris buffer, pH 8.0, 1mMDTT, 1X Protease inhibitors, 0.4 U/μl RNAse inhibitors, 0.2 U/μl Superasin). .. 500 μl of the resulting suspension was layered over 500 μl 29% iodixanol solution (29% v/v of 50% iodixanol, diluted with NIM, supplemented with DTT (1mM), Protease inhibitors (1X), RNAse inhibitors (0.4 U/μl), Superasin (0.2 U/μl)) in a 2.2ml Centrifugation:Article Title: Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer. Article Snippet: To remove debris, samples were subjected to equilibriumdensity centrifugation: sample pellets were first resuspended in 250 μl HB and thenmixed 1:1 with 50% iodixanol solution Nature Communications | (2025) 16:11338 9 (50% v/vOptiPrepTM (Sigma), 25mMKCl, 5mMMgCl2, 10mMtris buffer, pH 8.0, 1mMDTT, 1X Protease inhibitors, 0.4 U/μl RNAse inhibitors, 0.2 U/μl Superasin). .. 500 μl of the resulting suspension was layered over 500 μl 29% iodixanol solution (29% v/v of 50% iodixanol, diluted with NIM, supplemented with DTT (1mM), Protease inhibitors (1X), RNAse inhibitors (0.4 U/μl), Superasin (0.2 U/μl)) in a 2.2ml Article Title: The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits. Article Snippet: Background: The liver is a key organ in lipid and lipoprotein metabolism.. It has been postulated that a small diameter of sinusoidal fenestrae retards clearance of chylomicron remnants, resulting in hypercholesterolemia and atherosclerosis.. However, this hypothesis has not been rigorously tested hitherto. Clinical Proteomics:Article Title: The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits. Article Snippet: Background: The liver is a key organ in lipid and lipoprotein metabolism.. It has been postulated that a small diameter of sinusoidal fenestrae retards clearance of chylomicron remnants, resulting in hypercholesterolemia and atherosclerosis.. However, this hypothesis has not been rigorously tested hitherto. |